Brief: Bio Vitos Pharma Gets Patent For Succifer

Bio Vitos Pharma AB

20/12/2023 07:06

Dec 20 (Reuters) - Bio Vitos Pharma AB  BIOVIT.ST :
    * EUROPEAN PATENT OFFICE (EPO) HAS GRANTED A PATENT FOR
TREATMENT
OF HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION, WITH
ORAL IRON SUCCINATE
    * PATENT PROVIDES PROTECTION IN 26 COUNTRIES AND BIO VITOS
PHARMA
OWNS RIGHTS TO THIS PATENT WITHIN EU EXCLUDING NORDIC COUNTRIES
    * PATENT IS FOR OUR IRON SUCCINATE PRODUCT SUCCIFER

Source text for Eikon:  ID:nWkr5XhBBG 
Further company coverage:  BIOVIT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))